Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients (original) (raw)
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients
Silvia L Bucciarelli
Annals of the Rheumatic Diseases, 2008
View PDFchevron_right
Antiphospholipid Syndrome in Systemic Lupus Erythematosus: Is the Whole Greater Than the Sum of Its Parts?
Carl LASKIN
Rheumatic Disease Clinics of North America, 2005
View PDFchevron_right
Longterm Outcome of Patients with Primary Antiphospholipid Syndrome: A Retrospective Multicenter Study
Marta Tonello
The Journal of Rheumatology, 2017
View PDFchevron_right
Predictors of mortality in primary antiphospholipid syndrome. A single-centre cohort study
Giovanna D'Andrea
Thrombosis and haemostasis, 2016
View PDFchevron_right
Antiphospholipid Syndrome - An Evolving Story of a Multisystemic Disease
E. Nigel Harris
View PDFchevron_right
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome
Vittorio Pengo, P. Gresele
Journal of Thrombosis and Haemostasis, 2010
View PDFchevron_right
Antiphospholipid syndrome: state of the art on clinical practice guidelines
Linda Carli
RMD open, 2018
View PDFchevron_right
Diagnosis and classification of the antiphospholipid syndrome
Cecilia Valo
View PDFchevron_right
Guidelines on the investigation and management of antiphospholipid syndrome
Ayagoz Umbetzhanova, Gary Moore
View PDFchevron_right
Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients
Marta Baleva
Arthritis & Rheumatism, 2002
View PDFchevron_right
EULAR recommendations for the management of antiphospholipid syndrome in adults
Maria Tektonidou
Annals of the Rheumatic Diseases, 2019
View PDFchevron_right
Diagnosis and therapy of antiphospholipid syndrome
Vittorio Pengo
Polskie Archiwum Medycyny Wewnętrznej, 2015
View PDFchevron_right
Management of the antiphospholipid syndrome
Ricard Cervera, Gerard Espinosa
Autoimmunity Highlights, 2010
View PDFchevron_right
How we diagnose the antiphospholipid syndrome
B. Giannakopoulos
Blood, 2008
View PDFchevron_right
Diagnosis of antiphospholipid syndrome in routine clinical practice
Chris Gardiner
Lupus, 2013
View PDFchevron_right
Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events
Kenji Oku
Arthritis & Rheumatism, 2012
View PDFchevron_right
Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?
Francesca Pregnolato
Current Opinion in Rheumatology, 2009
View PDFchevron_right
Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers
Cecilia Chighizola
Arthritis Research & Therapy, 2014
View PDFchevron_right
A 15-year single centre retrospective study of antiphospholipid syndrome patients from Northern Malaysia
Wong Keng, Siew Hua Gan
View PDFchevron_right
Insights into the diagnosis and pathogenesis of the antiphospholipid syndrome
Imad Uthman
Seminars in Arthritis and Rheumatism, 2019
View PDFchevron_right
Atypical clinical manifestation of antiphospholipid syndrome
Bogusław Okopień
Polskie Archiwum Medycyny Wewnętrznej
View PDFchevron_right
A Comparison of Lupus Anticoagulant Positive Patients With Clinical Picture of Antiphospholipid Syndrome and Those Without
Vittorio Pengo, P. Gresele
Arteriosclerosis Thrombosis and Vascular Biology, 2007
View PDFchevron_right
C0460: Thrombotic Antiphospholipid Syndrome (APS): One Single Center Experience
Adela Periago
Thrombosis Research, 2014
View PDFchevron_right
Cardiovascular disease in the antiphospholipid syndrome
Adriana Rojas-Villarraga
Lupus, 2014
View PDFchevron_right
Primary antiphospholipid syndrome: pregnancy outcome in a portuguese population
Fátima Serrano
Acta Reumatológica Portuguesa, 2009
View PDFchevron_right
Antiphospholipid syndrome and the risk of myocardial infarction: current evidence and uncertainties
Zsuzsa Bagoly
Kardiologia Polska, 2019
View PDFchevron_right
Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality
gregorio soler
Lupus, 2020
View PDFchevron_right
Maternal and neonatal outcome in women with Antiphospholipid Syndrome and Systemic Lupus erythematodes
Uwe Lang
Gynaecologia et Perinatologia
View PDFchevron_right
Antiphospholipid syndrome in Asians: clinical manifestations, serological markers and outcome of the National University of Singapore/National University Hospital antiphospholipid cohort
Swee Cheng Ng
APLAR Journal of Rheumatology, 2003
View PDFchevron_right
The spectrum between antiphospholipid syndrome and systemic lupus erythematosus
Nancy Agmon-Levin
Clinical Rheumatology, 2014
View PDFchevron_right